Citadel Advisors’s NOVONIX NVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.4K Sell
12,051
-14,589
-55% -$97.1K ﹤0.01% 13073
2026
Q1
$184K Buy
26,640
+22,132
+491% +$215K ﹤0.01% 11496
2025
Q4
$45.5K Sell
4,508
-6,429
-59% -$91.2K ﹤0.01% 12074
2025
Q3
$140K Buy
10,937
+9,909
+964% +$129K ﹤0.01% 11585
2025
Q2
$10.4K Buy
+1,028
New +$11.8K ﹤0.01% 12197
2024
Q3
– Sell
-2,686
Closed -$48.1K – 14924
2024
Q2
$48.1K Sell
2,686
-1,442
-35% -$32.2K ﹤0.01% 11806
2024
Q1
$94.5K Buy
+4,128
New +$83.3K ﹤0.01% 11439

Other funds holding NVX

Citadel Advisors's NVX Position: Q2 2026 in Review

Citadel Advisors reduced its NOVONIX (NVX) stake by 55% in Q2 2026, selling an estimated $97.1K and leaving 12,051 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #13073.

Citadel Advisors first reported a position in NVX in Q1 2024 and has held it in 7 quarters since. The position peaked at $184K in Q1 2026. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Citadel Advisors held 12,051 shares of NOVONIX worth $55.4K as of Q2 2026.
  • Citadel Advisors sold 14,589 NOVONIX shares in Q2 2026, an estimated $97.1K.
  • NOVONIX made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13073 holding.
  • Citadel Advisors first reported a position in NOVONIX in Q1 2024 and has held it in 7 quarters since.
  • Citadel Advisors's NOVONIX position peaked at $184K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.